Literature DB >> 11261642

Gender aspects in schizophrenia: bridging the border between social and biological psychiatry.

A Riecher-Rössler1, H Häfner.   

Abstract

OBJECTIVE: This paper tries to show that gender differences in mental diseases are a valuable paradigm for research into the interplay between biological and psychosocial factors--not only regarding pathogenetic mechanisms, but also concerning therapeutic approaches.
METHOD: Based on relevant literature, this topic is highlighted using schizophrenia as an example.
RESULTS: Schizophrenic disorders show a later age of onset in women and a slightly better course, especially in young women. As to pathogenesis, there is some evidence that the age difference might be due at least partly to the female sex hormone oestradiol being a protective factor. Differences in course might also have to do with this biological factor, but at the same time with the psychosocial advantages of a higher age of onset and other psychosocial factors. Concerning therapy, these gender differences have important implications for pharmacotherapy, but also psychotherapy and social measures.
CONCLUSION: A gender-sensitive approach in psychiatry improves our understanding of mental illness and our therapeutic strategies and at the same time illustrates that comprehensive psychiatry cannot be practised in artificially separated 'drawers' called 'biological psychiatry', on one hand, and 'social psychiatry' on the other.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11261642     DOI: 10.1034/j.1600-0447.2000.00011.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand Suppl        ISSN: 0065-1591


  35 in total

1.  Evidence of a sex-dependent restrictive epigenome in schizophrenia.

Authors:  Kayla A Chase; Cherise Rosen; Leah H Rubin; Benjamin Feiner; Anjuli S Bodapati; Hannah Gin; Edward Hu; Rajiv P Sharma
Journal:  J Psychiatr Res       Date:  2015-04-18       Impact factor: 4.791

2.  Gender differences in symptoms, functioning and social support in patients at ultra-high risk for developing a psychotic disorder.

Authors:  Rachael K Willhite; Tara A Niendam; Carrie E Bearden; Jamie Zinberg; Mary P O'Brien; Tyrone D Cannon
Journal:  Schizophr Res       Date:  2008-06-24       Impact factor: 4.939

3.  Are there developmentally limited forms of bipolar disorder?

Authors:  David C Cicero; Amee J Epler; Kenneth J Sher
Journal:  J Abnorm Psychol       Date:  2009-08

4.  Association Between Age at Onset of Schizophrenia and Age at Menarche.

Authors:  Esin Evren Kiliçaslan; Almila Erol; Burçak Zengin; Pınar Çetinay Aydin; Levent Mete
Journal:  Noro Psikiyatr Ars       Date:  2014-09-01       Impact factor: 1.339

5.  Contrasting effects of increased and decreased dopamine transmission on latent inhibition in ovariectomized rats and their modulation by 17beta-estradiol: an animal model of menopausal psychosis?

Authors:  Michal Arad; Ina Weiner
Journal:  Neuropsychopharmacology       Date:  2010-03-17       Impact factor: 7.853

6.  [Resources in schizophrenic patients. Validity testing of a new rating scale to assess health features].

Authors:  S D Meister; H-J Haug
Journal:  Nervenarzt       Date:  2004-05       Impact factor: 1.214

7.  Differences among Men and Women with Schizophrenia: A Study of US and Indian Samples.

Authors:  Pramod Thomas; Joel Wood; Abha Chandra; Vishwajit L Nimgaonkar; Smita N Deshpande
Journal:  Psychiatry Investig       Date:  2010-03-10       Impact factor: 2.505

Review 8.  Kynurenines, Gender and Neuroinflammation; Showcase Schizophrenia.

Authors:  J de Bie; C K Lim; G J Guillemin
Journal:  Neurotox Res       Date:  2016-06-24       Impact factor: 3.911

9.  Predictors of outcome in brief cognitive behavior therapy for schizophrenia.

Authors:  Alison Brabban; Sara Tai; Douglas Turkington
Journal:  Schizophr Bull       Date:  2009-07-01       Impact factor: 9.306

10.  Gender differences in first episode psychosis.

Authors:  Anne Køster; Matilde Lajer; Anne Lindhardt; Bent Rosenbaum
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2008-06-20       Impact factor: 4.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.